Chautauqua Guest Home #2 | |
602 Eleventh Street, Charles City, Iowa 50616 | |
(641) 228-2353 | |
Name | Chautauqua Guest Home #2 |
---|---|
Location | 602 Eleventh Street, Charles City, Iowa |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 53 |
Occupancy Rate | 65.28% |
Medicare ID (CCN) | 165019 |
Legal Business Name | Chautauqua Guest Homes Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1538161971 |
Organization Name | CHAUTAUQUA GUEST HOMES, INC. |
Address | 602 11th St, Charles City, IA 50616 |
Phone Number | 641-228-2353 |
News Archive
When a host cell is infected with HIV, the virus brings its own genetic material into the host cell. This cell then replicates, reads the viral RNA, and uses it as a blueprint to produce more viral proteins.
Cell Therapeutics, Inc. announced today that it has been added to the Russell 3000, Russell 2000 and Russell Global Indexes posted by Russell Investments on June 27, 2011.
Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).
Parkinson's disease is characterized by a decline in the functions of the central nervous system, such as motor skills and speech. Several studies have shown an increased risk of dementia in first-degree relatives of Parkinson's disease patients, while other studies have not confirmed the association, according to background information in the article.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
When a host cell is infected with HIV, the virus brings its own genetic material into the host cell. This cell then replicates, reads the viral RNA, and uses it as a blueprint to produce more viral proteins.
Cell Therapeutics, Inc. announced today that it has been added to the Russell 3000, Russell 2000 and Russell Global Indexes posted by Russell Investments on June 27, 2011.
Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).
Parkinson's disease is characterized by a decline in the functions of the central nervous system, such as motor skills and speech. Several studies have shown an increased risk of dementia in first-degree relatives of Parkinson's disease patients, while other studies have not confirmed the association, according to background information in the article.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.28 | 14.46 |
Percentage of long-stay residents who lose too much weight | 13.38 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.06 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.27 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.27 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.92 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 14.29 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.73 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 11.11 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 37.76 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.22 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |